Total Payments
$40,399
2024 Payments
$5,361
Companies
18
Transactions
109
Medicare Patients
3,229
Medicare Billing
$433,909
Payment Breakdown by Category
Other$18,850 (46.7%)
Consulting$14,050 (34.8%)
Food & Beverage$3,928 (9.7%)
Travel$3,531 (8.7%)
Education$39.14 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,850 | 11 | 46.7% |
| Consulting Fee | $14,050 | 10 | 34.8% |
| Food and Beverage | $3,928 | 71 | 9.7% |
| Travel and Lodging | $3,531 | 16 | 8.7% |
| Education | $39.14 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NxStage Medical, Inc. | $29,140 | 49 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $9,927 | 16 | $0 (2024) |
| Amgen Inc. | $371.14 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $163.24 | 6 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2021) |
| CALLIDITAS THERAPEUTICS US INC. | $115.52 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $79.78 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $75.08 | 3 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $73.39 | 3 | $0 (2024) |
| Baxter Healthcare | $64.40 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,361 | 31 | Fresenius USA Marketing, Inc. ($4,564) |
| 2023 | $8,177 | 29 | Fresenius USA Marketing, Inc. ($5,364) |
| 2022 | $2,542 | 3 | NxStage Medical, Inc. ($2,519) |
| 2021 | $1,567 | 4 | NxStage Medical, Inc. ($1,418) |
| 2020 | $7,000 | 6 | NxStage Medical, Inc. ($7,000) |
| 2019 | $1,232 | 6 | NxStage Medical, Inc. ($1,232) |
| 2018 | $7,211 | 19 | NxStage Medical, Inc. ($7,187) |
| 2017 | $7,308 | 11 | NxStage Medical, Inc. ($7,288) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $31.68 | General |
| 09/05/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $18.04 | General |
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.04 | General |
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Cardio-renal | ||||||
| 08/09/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $73.81 | General |
| 08/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $49.20 | General |
| Category: Inflammation | ||||||
| 08/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $59.78 | General |
| Category: Nephrology | ||||||
| 08/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $49.20 | General |
| Category: Inflammation | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.47 | General |
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Inflammation | ||||||
| 05/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Cardio-renal | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/26/2024 | Fresenius USA Marketing, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 03/26/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $404.90 | General |
| 03/26/2024 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $94.47 | General |
| 03/26/2024 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $34.10 | General |
| 03/25/2024 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $639.20 | General |
| 03/25/2024 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $191.03 | General |
| 03/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Inflammation | ||||||
| 03/14/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Nephrology | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 692 | 1,195 | $230,158 | $91,986 |
| 2022 | 12 | 763 | 1,524 | $251,874 | $99,424 |
| 2021 | 10 | 825 | 1,431 | $268,759 | $111,499 |
| 2020 | 10 | 949 | 1,689 | $369,731 | $131,000 |
Total Patients
3,229
Total Services
5,839
Medicare Billing
$433,909
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 225 | 517 | $84,119 | $34,980 | 41.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 114 | 131 | $35,909 | $14,573 | 40.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 110 | 220 | $32,709 | $13,372 | 40.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 58 | $21,144 | $8,599 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 99 | $26,744 | $8,442 | 31.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 37 | 97 | $17,058 | $7,008 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,740 | $2,289 | 39.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 35 | 43 | $4,508 | $1,854 | 41.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $2,226 | $869.88 | 39.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 233 | 561 | $83,589 | $33,839 | 40.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 123 | 262 | $41,134 | $16,057 | 39.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 83 | 96 | $27,456 | $11,103 | 40.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 63 | 132 | $23,628 | $9,627 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 92 | $26,864 | $9,296 | 34.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 54 | $22,626 | $9,103 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $6,160 | $3,617 | 58.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 28 | $5,964 | $2,447 | 41.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 40 | 46 | $3,726 | $1,474 | 39.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 16 | $3,408 | $1,395 | 40.9% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2022 | 12 | 191 | $6,509 | $1,243 | 19.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 18 | $810.00 | $222.01 | 27.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 212 | 501 | $74,649 | $31,036 | 41.6% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 154 | 313 | $49,141 | $19,725 | 40.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 119 | 136 | $38,896 | $16,070 | 41.3% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 58 | 154 | $27,566 | $11,512 | 41.8% |
About Dr. Roger Rodby, MD
Dr. Roger Rodby, MD is a Nephrology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043327927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Rodby, MD has received a total of $40,399 in payments from pharmaceutical and medical device companies, with $5,361 received in 2024. These payments were reported across 109 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,850).
As a Medicare-enrolled provider, Rodby has provided services to 3,229 Medicare beneficiaries, totaling 5,839 services with total Medicare billing of $433,909. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Chicago, IL
- Active Since 08/24/2006
- Last Updated 09/25/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1043327927
Products in Payments
- System One (Device) $17,003
- NXSTAGE SYSTEM ONE (Device) $10,445
- Cartridges-Pure Flow (Device) $5,500
- TAVNEOS (Drug) $223.28
- TARPEYO (Drug) $115.52
- FARXIGA (Drug) $100.37
- Kerendia (Drug) $75.08
- LUPKYNIS (Drug) $73.39
- LOKELMA (Drug) $62.87
- ACTHAR (Biological) $57.83
- Aranesp (Biological) $53.55
- JYNARQUE (Drug) $47.87
- SYSTEM ONE (Device) $43.57
- Renal - Amia (Device) $40.82
- JESDUVROQ (Drug) $39.14
- CARTRIDGES (Device) $38.78
- JARDIANCE (Drug) $24.87
- Renal - PD (Device) $23.58
- IBSRELA (Drug) $22.93
- None/NxStage Kidney Care (Device) $22.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chicago
Nicole Stankus
Nephrology — Payments: $241,812
Nephrology $241,812
Susan Quaggin, Md, MD
Nephrology — Payments: $235,919
Nephrology $235,919
Lorenzo Gallon, Md, MD
Nephrology — Payments: $187,956
Nephrology $187,956
John Friedewald, Md, MD
Nephrology — Payments: $131,619
Nephrology $131,619
Arlene Chapman
Nephrology — Payments: $125,467
Nephrology $125,467
Dr. Jay Koyner, M.d, M.D
Nephrology — Payments: $87,521
Nephrology $87,521